Venus Concept Inc. (NASDAQ:VERO) Sees Large Decline in Short Interest

Venus Concept Inc. (NASDAQ:VERO) was the target of a significant drop in short interest in the month of January. As of January 15th, there was short interest totalling 55,500 shares, a drop of 42.6% from the December 31st total of 96,700 shares. Based on an average daily trading volume, of 946,700 shares, the short-interest ratio is presently 0.1 days. Approximately 1.3% of the company’s stock are short sold.

Venus Concept Stock Down 3.5 %

Shares of Venus Concept stock opened at $0.35 on Friday. Venus Concept has a 1 year low of $0.28 and a 1 year high of $2.22. The company has a 50-day moving average of $0.35 and a 200 day moving average of $0.47. The firm has a market cap of $2.51 million, a price-to-earnings ratio of -0.04 and a beta of 0.47. The company has a debt-to-equity ratio of 2.83, a current ratio of 1.86 and a quick ratio of 1.18.

About Venus Concept

Venus Concept Inc, a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin.